Happe Spine’s Integrate-C interbody fusion system has been implanted in more than 1,000 patients across 40 U.S. facilities.
The company said the milestone reflects growing clinical adoption of the bone-integrating implant platform, which is designed to enhance spinal fusion outcomes while eliminating imaging interference caused by traditional metal devices, according to a Nov. 13 news release.
The Integrate-C system is now used by more than 30 spine surgeons nationwide. Happe Spine recently closed an oversubscribed funding round to expand manufacturing and support additional clinical validation.
The company also completed the 2025 MedTech Innovator Accelerator program. Happe was one of 65 startups selected from nearly 1,500 global applicants.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
